Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes
Status:
Withdrawn
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
In this pilot study we are evaluating the efficacy of pramlintide on preventing weight gain
among early onset type 1 diabetes. We are also evaluating the safety and the effects of
treatment with pramlintide on early diagnosed type 1 diabetic subjects, especially among
pediatric subjects.